Holen Sie sich die Stockscreener-App
5.01
0.20%
0.010
Handel nachbörslich:
5.01
Schlusskurs vom Vortag:
$5.00
Offen:
$4.93
24-Stunden-Volumen:
364.79K
Relative Volume:
1.70
Marktkapitalisierung:
$137.01M
Einnahmen:
$61.86M
Nettoeinkommen (Verlust:
$-11.43M
KGV:
-10.40
EPS:
-0.4818
Netto-Cashflow:
$-12.52M
1W Leistung:
-3.28%
1M Leistung:
-3.09%
6M Leistung:
-44.82%
1J Leistung:
-26.65%
1-Tages-Spanne:
$4.83
$5.095
1-Wochen-Bereich:
$4.83
$5.37
52-Wochen-Spanne:
$4.31
$9.555
Journey Medical Corp Stock (DERM) Company Profile
Firmenname
Journey Medical Corp
Sektor
Telefon
480-434-6670
Adresse
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
5.01 | 136.73M | 61.86M | -11.43M | -12.52M | -0.4818 |
TAK
Takeda Pharmaceutical Co Adr
|
16.42 | 51.68B | 29.85B | 776.90M | 4.35B | 0.2408 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.81 | 41.73B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.10 | 39.86B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
76.94 | 32.14B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
581.74 | 24.19B | 3.17B | 1.29B | 1.01B | 27.09 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-30 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-06-28 | Fortgesetzt | ROTH MKM | Buy |
| 2021-12-07 | Eingeleitet | B. Riley Securities | Buy |
Journey Medical Corp Aktie (DERM) Neueste Nachrichten
TradingKey - TradingKey
Journey Medical Corp expected to post a loss of 8 cents a shareEarnings Preview - TradingView
DERM Stock Price, Quote & Chart | JOURNEY MEDICAL CORP (NASDAQ:DERM) - ChartMill
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in FS KKR Capital Corp. of Class Action Lawsuit and Upcoming DeadlinesFSK - PR Newswire
Journey Medical to discuss quarterly results and corporate update May 13 - Stock Titan
Will Journey Medical Corporation (DERM) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
Journey Medical (DERM) Expected to Announce Earnings on Wednesday - MarketBeat
Assertio (ASRT) Moves 17.0% Higher: Will This Strength Last? - Yahoo Finance
Fortress Biotech CEO to speak at royalty company virtual conference - Stock Titan
BioHarvest Chief Medical Officer Shares Personal Journey at Collision Conference - TMX Newsfile
MSN Money - MSN
10 Best Travel Insurance Companies For 2026 - Forbes
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Journey Medical CorporationDERM - ChartMill
Journey Medical (NASDAQ: DERM) details 2026 virtual meeting, board and pay - Stock Titan
Vanguard reports 1.21M-share stake in Journey Medical Corp (DERM) - Stock Titan
FBIO Stock Price, Quote & Chart | FORTRESS BIOTECH INC (NASDAQ:FBIO) - ChartMill
Q1 EPS Estimates for Journey Medical Cut by HC Wainwright - MarketBeat
Journey Medical Corporation (NASDAQ:DERM) Receives Average Rating of "Hold" from Analysts - MarketBeat
Journey Medical (DERM) COO receives new RSU and option grants - Stock Titan
Journey Medical (DERM) CFO receives new RSU and stock option grants - Stock Titan
Journey Medical (DERM) CEO granted RSUs and stock options - Stock Titan
Q4 EPS Estimates for Journey Medical Raised by HC Wainwright - MarketBeat
Journey Medical Expands Emrosi™ Coverage to Over 150 Million Commercial Lives with Third Major GPO Contract - Minichart
DERM Financials: Income Statement, Balance Sheet & Cash Flow | Journey Medical Corp - Stock Titan
Journey Medical Expands Emrosi Commercial Access Across U.S. - TipRanks
Journey Medical expands Emrosi payer access to 85% of US commercial lives - TradingView
Emrosi access reaches 85% of U.S. commercial lives at Journey Medical (Nasdaq: DERM) - Stock Titan
Rosacea drug Emrosi expands access to over 150 million U.S. lives - Stock Titan
Danone Sets New Sustainability Targets with Second Phase of Impact Journey - Food & Beverage Outlook
Is Journey Med (DERM) stock a favorable investment idea | Q4 2025: EPS Beats ForecastsCrowd Entry Signals - Newser
Stock List: Research Stocks from Around the World - GuruFocus
Journey Medical Corporation (NASDAQ:DERM) Short Interest Up 31.3% in March - MarketBeat
Journey Medical Corp stock (US48113J1007): Why does its dermatology focus matter more now for U.S. i - AD HOC NEWS
DERM SEC FilingsJourney Medical Corp 10-K, 10-Q, 8-K Forms - Stock Titan
DERM Technical Analysis & Stock Price Forecast - Intellectia AI
Personal trainer shocked to find health company using his photos - BBC
Journey Medical Corp stock: What investors need to know amid volatility - AD HOC NEWS
Wasatch Advisors holds 2.13M Journey Medical (NASDAQ: DERM) — 10% stake - Stock Titan
DERM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
DERM Stock Analysis: Journey Medical Corporation trades at $4.64 down 1.07% today - newser.com
Journey Medical Corporation (NASDAQ:DERM) Given Consensus Rating of “Hold” by Analysts - Defense World
Journey Medical Corporation (NASDAQ:DERM) Given Consensus Rating of "Hold" by Analysts - MarketBeat
US Stocks Recap: Can Journey Medical Corporation be the next market leaderPortfolio Profit Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Short Squeeze: Can Journey Medical Corporation reach all time highs this year2026 Investor Takeaways & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Rare-disease voucher sale brings Fortress more than $100M - Stock Titan
Why The Journey Medical (DERM) Narrative Is Shifting With New Targets And Going Concern Risks - Yahoo Finance
KALA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Aug Update: Can Journey Medical Corporation reach all time highs this yearWeekly Investment Report & Expert Curated Trade Setups - baoquankhu1.vn
Journey Medical (NASDAQ:DERM) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat
Journey Medical Corporation (NASDAQ:DERM) Q4 2025 Earnings Call Transcript - Insider Monkey
HC Wainwright Forecasts Journey Medical Q1 Earnings - MarketBeat
Finanzdaten der Journey Medical Corp-Aktie (DERM)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.18%
3.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):